drug development
How clinical trials infrastructure is undergoing digital transformation
Two years ago, many of us were confined to our homes trying to avoid Covid-19 and waiting for the pharmaceutical…
Genome Company Licenses Its First Drug – Thanks to Your DNA
23andMe built up a huge dataset – at a profit – by selling DNA tests to the public. Now the…
Algorithms vs Alzheimers? BenevolentAI Hits $2B High
London-based medtech startup BenevolentAI today (April 19) announced a further $114 million in funding, bringing the company’s valuation to over…
